@Babyhuntet, I don’t think you are missing anything. We all know that Galaxy has strategic partnership with Lepidico. In fact galaxy did very well with their investment, having bought a 12 percent stake in Lepidico (292m shares) at one cent in 2017 and now LPD shares at $.027.
It was a smart move and cost savings to using a clean unconventional L-Max technology of Lepidico which is located in Perth. The pilot plant has to proof itself and it will be commissioned in April this year as per Lepidico announcement on ASX last month.
It is also important that galaxy diversifies and looks at other options , strategic partner with proven processing technology and deep pockets like POSCO and nothing wrong with that. In fact it derisks it’s business model.
When Lepidico builds its plant in Sudbury in Canada which currently in full feasibility study and the results in Q2 2019, galaxy will have the option of using the implant to process what comes out of James Bay.
I would not be surprised if Galaxy takes a huge chunk of LPD if not taking the whole company over. Look at the chart of LPD and you will know what I mean.
Galaxy has many options and all the pieces are connecting together. MC and JB near LPD plants in Perth and Canada and SDV near POSCO. It is one big family with lots of synergies, hence cost savings and big margins
Galaxy is not just cash cow, it is a giant elephant in the rooms.
My thoughts only.
cheers, Sydney
GXY Price at posting:
$2.17 Sentiment: Buy Disclosure: Held
